Pharmacokinetics of Tolbutamide in acute renal failure induced by Glycerol: Speculative thoughts and Perspectives

Drug Metabolism and Pharmacokinetics

Volumn 26, Issue 2, 2011, Pages 216-217

  Srinivas, Nuggehally R ^a  

^a Suramus Biopharm   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GLYCEROL; OROSOMUCOID; QUINIDINE; SERUM ALBUMIN; TOLBUTAMIDE;

ACUTE KIDNEY FAILURE; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG EXCRETION; DRUG METABOLISM; LETTER; NONHUMAN; STOMACH EMPTYING; URINARY EXCRETION;

EID: 79955721022     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-09-LE-101     Document Type: Letter

References (12)

1. Izuwa, Y., Kusaba, J., Horiuchi, M., Aiba, T., Kawasaki, H. and Kurosaki, Y.: Comparative study of increased plasma quinidine concentration in rats with glycerol- and cisplatin-induced acute renal failure. Drug Metab. Pharmacokinet., 24: 451-457 (2009).
2. Choi, J. S. and Shin, S. C.: Pharmacokinetics of tolbutamide after oral administration to rabbits with folate-induced renal failure. Arch. Pharm. Res., 26: 979-983 (2003).
3. Patel, T. B., Rashed, H. M., Dyson, J. and Waller, F. M.: Stimulation of biliary glutathione secretion by sulfonylureas. Mol. Pharmacol., 31: 638-642 (1987).
4. Saitoh, H., Kobayashi, M., Oda, M., Nakasato, K., Kobayashi, M. and Tadano, K.: Characterization of intestinal absorption and enterohepatic circulation of mycophenolic acid and its 7-Oglucuronide in rats. Drug Metab. Pharmacokinet., 21: 406-413 (2006).
5. Kim, Y. G., Yoon, E. J., Yoon, W. H., Shim, H. J., Lee, S. D., Kim, W. B., Yang, J. and Lee, M. G.: Pharmacokinetics of DA-125, a new anthracycline, after intravenous administration to uranyl nitrate-induced acute renal failure rats or protein-calorie malnutrition rats. Biopharm. Drug Dispos., 17: 183-195 (1996).
6. Pepper, E. S. and Wosilait, W. D.: Multiple factors affecting excretion of warfarin in rats. Res. Commun. Chem. Pathol. Pharmacol., 18: 275-281 (1977).
7. Choi, Y. H., Lee, Y. S., Kim, T. K., Lee, B. Y. and Lee, M. G.: Faster clearance of mirodenafil in rats with acute renal failure induced by uranyl nitrate: contribution of increased protein expression of hepatic CYP3A1 and intestinal CYP1A1 and 3A1/2. J. Pharm. Pharmacol., 61: 1325-1332 (2009).
8. Moon, Y. J., Lee, A. K., Chung, H. C., Kim, E. J., Kim, S. H., Lee, D. C., Lee, I., Kim, S. G. and Lee, M. G.: Effects of acute renal failure on the pharmacokinetics of chlorzoxazone in rats. Drug Metab. Dispos., 31: 776-784 (2003).
9. Araya, H., Nagao, S., Tomita, M. and Hayashi, M.: The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion I: enhancing effects on oral bioavailability of poorly water soluble compounds in rats and beagle dogs. Drug Metab. Pharmacokinet., 20: 244-256 (2005).
10. Shibata, N., Ohmae, T., Hoshino, N., Minouchi, T. and Yamaji, A.: Influence of glycerol-induced acute renal failure on the pharmacokinetics of cyclosporine in rats. J. Pharm. Pharmacol., 51: 397-404 (1999).
11. Aiba, T., Horiuchi, M., Makita, T., Komori, Y., Kawasaki, H. and Kurosaki, Y.: Peritoneal dialysis alters tolbutamide pharmacokinetics in rats with experimental acute renal failure. Drug Metab. Pharmacokinet., 21: 291-296 (2006).
12. Makita, T., Aiba, T., Izuwa, Y., Komori, Y., Kawasaki, H. and Kurosaki, Y.: Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased. Biopharm. Drug Dispos., 30: 1-8 (2009).